{"groups":[{"description":"\\-- After the screening procedures confirm participation in the research study: The participant will be given a study drug-dosing calendar for each treatment cycle.\n\nDasatinib: Oral Study Drug(s):\n\n* Each study treatment cycle lasts 4 weeks during which time you will be taking the study drug one time per day.\n* This will continue for up to 24 cycles.\n\nDasatinib: Oral, daily, dosing per protocol, once a day for cycle","id":"FG000","title":"Dasatinib"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"1"}],"type":"Withdrawal by Subject"},{"reasons":[{"groupId":"FG000","numSubjects":"2"}],"type":"Lack of Efficacy"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"3"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"3"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}